Clinical Trial Update: Antiviral Efficacy of Switching to ETV Plus TDF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating antiviral efficacy when switching chronic hepatitis B patients to a combination of entecavir and tenofovir disoproxil fumarate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN